Rici Healthcare Holdings Ltd. (HK:1526)
:1526
Want to see HK:1526 full AI Analyst Report?
Top Page
Rici Healthcare Holdings Ltd.
(1526)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$0.96
▼(-3.54% Downside)
Action:ReiteratedDate:04/26/26
The score is supported mainly by solid financial performance (strong margins and cash flow) and an attractive low P/E valuation. These positives are tempered by weak technical positioning, with the stock trading below key moving averages and slightly negative momentum indicators.
Positive Factors
High and improving profitability
Sustained high gross and operating margins indicate durable unit economics and pricing power in the care facilities business. Strong margins provide buffer against cyclical revenue swings and support reinvestment, allowing consistent reinvestment in quality and service over the medium term.
Negative Factors
Meaningful residual debt load
A multi‑billion debt stock leaves limited balance‑sheet flexibility if operating results deteriorate. Interest and refinancing exposure can constrain capital allocation, forcing prioritization of debt service over growth or shareholder distributions during downdrafts.
Read all positive and negative factors
Positive Factors
Negative Factors
High and improving profitability
Sustained high gross and operating margins indicate durable unit economics and pricing power in the care facilities business. Strong margins provide buffer against cyclical revenue swings and support reinvestment, allowing consistent reinvestment in quality and service over the medium term.
Read all positive factors
Rici Healthcare Holdings Ltd. (1526) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.40B
Dividend Yield4.37%
Average Volume (3M)125.43K
Price to Earnings (P/E)5.3
Beta (1Y)0.31
Revenue Growth-4.23%
EPS Growth3.95%
CountryHK
Employees8,908
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.17
Shares Outstanding1,590,324,000
10 Day Avg. Volume143,000
30 Day Avg. Volume125,433
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.97
Price to Sales (P/S)0.59
P/FCF Ratio2.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rici Healthcare Holdings Ltd. Business Overview & Revenue Model
Company Description
Rici Healthcare Holdings Ltd. (1526) is a healthcare investment company based in Hong Kong, primarily focusing on the development, manufacturing, and distribution of medical devices and healthcare products. The company operates within the healthca...
How the Company Makes Money
null...
Rici Healthcare Holdings Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
64
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.27B | 2.72B | 2.92B | 2.99B | 2.38B | 2.38B |
| Gross Profit | 975.27M | 1.18B | 1.17B | 1.25B | 927.20M | 975.22M |
| EBITDA | 651.40M | 1.04B | 798.69M | 1.07B | 572.61M | 682.80M |
| Net Income | 240.30M | 299.18M | 297.32M | 363.80M | 290.79M | 181.55M |
Balance Sheet | ||||||
| Total Assets | 4.72B | 4.88B | 4.86B | 4.64B | 4.57B | 4.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.18B | 1.12B | 811.21M | 720.14M | 784.36M |
| Total Debt | 2.25B | 2.01B | 2.30B | 2.27B | 2.30B | 2.74B |
| Total Liabilities | 3.30B | 3.16B | 3.48B | 3.52B | 3.66B | 3.95B |
| Stockholders Equity | 1.40B | 1.65B | 1.35B | 1.13B | 953.92M | 677.50M |
Cash Flow | ||||||
| Free Cash Flow | 311.65M | 561.55M | 584.35M | 487.07M | 396.33M | 356.41M |
| Operating Cash Flow | 358.39M | 719.39M | 790.58M | 826.29M | 706.37M | 681.07M |
| Investing Cash Flow | -15.50M | -301.48M | -140.02M | -147.00M | -273.99M | -269.13M |
| Financing Cash Flow | -81.44M | -388.92M | -351.23M | -592.72M | -495.23M | -193.99M |
Rici Healthcare Holdings Ltd. Technical Analysis
Negative
0.99
Price Trends
0.91
Negative
0.95
Negative
1.00
Negative
Market Momentum
<0.01
Negative
48.78
Neutral
36.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Negative. The current price of 0.99 is above the 20-day moving average (MA) of 0.90, above the 50-day MA of 0.91, and below the 200-day MA of 1.00, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 48.78 is Neutral, neither overbought nor oversold. The STOCH value of 36.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1526.
Rici Healthcare Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$672.13M | 2.28 | 5.29% | 9.14% | -1.48% | 549.60% | |
67 Neutral | HK$1.40B | 5.35 | 18.05% | 4.37% | -4.23% | 3.95% | |
56 Neutral | HK$483.68M | -10.63 | 27.04% | ― | 2.00% | ― | |
52 Neutral | HK$307.44M | 4.11 | 3.54% | 3.75% | 9.74% | 32.37% | |
52 Neutral | HK$1.67B | 117.78 | 0.48% | 0.49% | -2.63% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | -275.87 | 1.85% | ― | -13.22% | -69.35% |
* Healthcare Sector Average
HK:1526
Rici Healthcare Holdings Ltd.
0.88
-0.09
-9.28%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.02
1.30%
HK:1419
Human Health Holdings Ltd.
0.81
0.05
6.58%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.04
0.25
13.97%
HK:3869
Hospital Corporation of China Ltd
3.50
-3.30
-48.53%
HK:3886
Town Health International Medical Group Ltd.
0.24
0.00
0.00%
Rici Healthcare Holdings Ltd. Corporate Events
Rici Healthcare Sets AGM to Approve 2025 Results, Dividend and Share Issuance Mandate
Apr 22, 2026
Rici Healthcare Holdings has called its annual general meeting for June 17, 2026, in Shanghai, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the year end...
Rici Healthcare Revamps Company Secretary Role and Moves Hong Kong Office
Mar 26, 2026
Rici Healthcare Holdings Limited announced changes to its corporate governance team, with company secretary and authorised representative Chen Kun resigning effective March 26, 2026, and confirming there is no matter relating to his departure that...
Rici Healthcare lifts 2025 profit on stronger margins despite revenue decline
Mar 26, 2026
Rici Healthcare Holdings reported 2025 revenue of RMB2.80 billion, a 4.4% decline from the previous year, but improved profitability with gross profit up 3.4% to RMB1.21 billion. Profit attributable to shareholders rose to RMB307.1 million from RM...
Rici Healthcare Declares Final HKD 0.02 Dividend for 2025
Mar 26, 2026
Rici Healthcare Holdings Ltd. has declared a final ordinary cash dividend of HKD 0.02 per share for the financial year ended 31 December 2025, payable in Hong Kong dollars. The dividend will be subject to shareholder approval on 17 June 2026, with...
Rici Healthcare Schedules Board Meeting to Approve 2025 Results and Consider Dividend
Mar 12, 2026
Rici Healthcare Holdings has scheduled a board meeting for March 26, 2026 to review and approve the audited annual results for the year ended December 31, 2025, and to authorize their publication. The board will also consider the payment of a fina...
Rici Healthcare Details Shanghai Property Purchase as Long-Term Investment and Cash Diversifier
Feb 4, 2026
Rici Healthcare Holdings Ltd. has provided additional details on its recently announced acquisition of a residential property in Shanghai’s Xuhui District, positioning the deal as a medium- to long-term investment that leverages the positive...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.